MD Anderson shares latest research breakthroughs

Peer-Reviewed Publication University of Texas M. D. Anderson Cancer Center FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail HER2-targeted therapy showed durable and clinically meaningful results for patients with rare bile duct cancers Researchers identified promising therapeutic targets for KRAS-mutant cancers and kidney cancers Study provides insights into AI models for genomic analysis and clinical decision-making Researchers uncovered how DNA shape and rigidity […]

MD Anderson shares latest research breakthroughs Read More »